

INNOPHAR
Pharmaceutical Manufacturing • Germany • 1-10 Employees
Company overview
| Headquarters | Germany |
| Website | |
| NAICS | 3254 |
| Founded | 2005 |
| Employees | 1-10 |
Key Contact at INNOPHAR
Franz Janik
Geschäftsführer; Business Development Director
About INNOPHAR
CRO for special studies. Focused on special patient populations for non-therapeutic benefit studies covering all major indications such as oncology, renal and hepatic diseases, CNS, cardiovascular diseases, and others. Typical examples include pharmacokinetic (PK) - pharmacodynamic (PD) and Proof-of-Concept (PoC) trials with patients in various disease stages Early phase development Proof of Concept PK/PD in the target and special populations Guaranteed fast recruitment rate
INNOPHAR revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
INNOPHAR has never raised funding before.
Frequently asked questions
4.8
40,000 users



